10-Q Filing

Dominari Holdings Inc. CIK: 12239 Q1 2022

Filing Information

Form Type	10-Q
Accession Number	`0001213900-22-027192`
Period End Date	20220331
Filing Date	20220516
Fiscal Year	2022
Fiscal Period	Q1
XBRL Instance	f10q0322_aikidopharma_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 66 Income Statement 30 Cash Flow Statement 63 Stockholders Equity 20

Balance Sheet 66 line items

Line Item	Tag	Value	Unit	Period
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$49.69M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$65.56M	USD	Point-in-time
Restricted cash	`RestrictedCashCurrent`	$20.95M	USD	Point-in-time
Marketable securities	`MarketableSecurityCurrent`	$14.44M	USD	Point-in-time
Marketable securities	`MarketableSecurityCurrent`	$11.43M	USD	Point-in-time
Prepaid expenses and other assets	`PrepaidExpenseAndOtherAssetsCurrent`	$442.00K	USD	Point-in-time
Prepaid expenses and other assets	`PrepaidExpenseAndOtherAssetsCurrent`	$348.00K	USD	Point-in-time
Short-term investments at fair value	`ShortTermInvestments`	$2.27M	USD	Point-in-time
Short-term investments at fair value	`ShortTermInvestments`	$255.00K	USD	Point-in-time
Notes receivable at fair value	`NotesReceivableRelatedPartiesCurrent`	$6.98M	USD	Point-in-time
Notes receivable at fair value	`NotesReceivableRelatedPartiesCurrent`	$9.31M	USD	Point-in-time
Deposits	`DepositsAssetsCurrent`	$4.20M	USD	Point-in-time
Deposits	`DepositsAssetsCurrent`	$4.19M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$90.89M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$99.18M	USD	Point-in-time
Convertible note receivable at fair value	`NotesReceivableRelatedPartiesNoncurrent`	$2.15M	USD	Point-in-time
Investments	`Investments`	$9.46M	USD	Point-in-time
Investments	`Investments`	$18.61M	USD	Point-in-time
Security deposit	`SecurityDeposit`	$155.00K	USD	Point-in-time
Preferred stock, par value (in Dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Security deposit	`SecurityDeposit`	$155.00K	USD	Point-in-time
Preferred stock, par value (in Dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, authorized	`PreferredStockSharesAuthorized`	50.00M	shares	Point-in-time
Preferred stock, authorized	`PreferredStockSharesAuthorized`	50.00M	shares	Point-in-time
Total assets	`Assets`	$102.66M	USD	Point-in-time
Total assets	`Assets`	$117.95M	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$209.00K	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$381.00K	USD	Point-in-time
Accrued salaries and benefits	`EmployeeRelatedLiabilitiesCurrent`	$680.00K	USD	Point-in-time
Accrued salaries and benefits	`EmployeeRelatedLiabilitiesCurrent`	$686.00K	USD	Point-in-time
Common stock, par value (in Dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in Dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$895.00K	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.06M	USD	Point-in-time
Total liabilities	`Liabilities`	$895.00K	USD	Point-in-time
Total liabilities	`Liabilities`	$1.06M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	89.29M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	89.68M	shares	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	89.29M	shares	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	89.68M	shares	Point-in-time
Series O Redeemable Convertible Preferred Stock, $0.0001 par value; 11,000 and 0 shares issued and outstanding, at $1,000.00 per share at March 31, 2022 and December 31, 2021	`TemporaryEquityCarryingAmountAttributableToParent`	$11.00M	USD	Point-in-time
Series P Redeemable Convertible Preferred Stock, $0.0001 par value; 11,000 and 0 shares issued and outstanding, at $1,000.00 per share at March 31, 2022 and December 31, 2021	`TemporaryEquityCarryingAmountAttributableToParentOne`	$11.00M	USD	Point-in-time
Preferred stock, $.0001 par value, 50,000,000 Authorized	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $.0001 par value, 50,000,000 Authorized	`PreferredStockValue`	-	USD	Point-in-time
Series D: 5,000,000 shares designated; 3,825 shares issued and outstanding at March 31, 2022 and December 31, 2021; liquidation value of $0.0001 per share	`PreferredStockValueOne`	-	USD	Point-in-time
Series D: 5,000,000 shares designated; 3,825 shares issued and outstanding at March 31, 2022 and December 31, 2021; liquidation value of $0.0001 per share	`PreferredStockValueOne`	-	USD	Point-in-time
Series D-1: 5,000,000 shares designated; 834 shares issued and outstanding at March 31, 2022 and December 31, 2021; liquidation value of $0.0001 per share	`PreferredStockValueTwo`	-	USD	Point-in-time
Series D-1: 5,000,000 shares designated; 834 shares issued and outstanding at March 31, 2022 and December 31, 2021; liquidation value of $0.0001 per share	`PreferredStockValueTwo`	-	USD	Point-in-time
Common stock, $0.0001 par value, 100,000,000 shares authorized; 89,293,446 and 89,681,258 shares issued at March 31, 2022 and December 31, 2021, respectively; 89,293,443 and 89,681,255 shares outstanding at March 31, 2022 and December 31, 2021, respectively	`CommonStockValue`	$9.00K	USD	Point-in-time
Common stock, $0.0001 par value, 100,000,000 shares authorized; 89,293,446 and 89,681,258 shares issued at March 31, 2022 and December 31, 2021, respectively; 89,293,443 and 89,681,255 shares outstanding at March 31, 2022 and December 31, 2021, respectively	`CommonStockValue`	$9.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$265.62M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$262.62M	USD	Point-in-time
Treasury stock, at cost, 3 shares at March 31, 2022 and December 31, 2021	`TreasuryStockValue`	$264.00K	USD	Point-in-time
Treasury stock, at cost, 3 shares at March 31, 2022 and December 31, 2021	`TreasuryStockValue`	$264.00K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-163.77M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-167.31M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$101.59M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$104.37M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$95.05M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$29.62M	USD	Point-in-time
Total liabilities, redeemable convertible preferred stock and stockholders equity	`LiabilitiesAndStockholdersEquity`	$102.66M	USD	Point-in-time
Total liabilities, redeemable convertible preferred stock and stockholders equity	`LiabilitiesAndStockholdersEquity`	$117.95M	USD	Point-in-time

Income Statement 30 line items

Line Item	Tag	Value	Unit	Period
General and administrative	`SellingGeneralAndAdministrativeExpense`	$1.79M	USD	1 Quarter
General and administrative	`SellingGeneralAndAdministrativeExpense`	$1.21M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$2.02M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$72.00K	USD	1 Quarter
Research and development - license acquired	`ResearchAndDevelopmentLicenseAcquired`	$1.03M	USD	1 Quarter
Research and development - license acquired	`ResearchAndDevelopmentLicenseAcquired`	-	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$3.80M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$2.32M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-2.32M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-3.80M	USD	1 Quarter
Other income	`OtherIncome`	$135.00K	USD	1 Quarter
Other income	`OtherIncome`	$64.00K	USD	1 Quarter
Interest income	`InterestIncomeExpenseNet`	$179.00K	USD	1 Quarter
Interest income	`InterestIncomeExpenseNet`	$27.00K	USD	1 Quarter
Loss on marketable securities	`MarketableSecuritiesGainLoss`	$-497.00K	USD	1 Quarter
Loss on marketable securities	`MarketableSecuritiesGainLoss`	$-1.34M	USD	1 Quarter
Change in fair value of investment	`GainLossOnInvestments`	$522.00K	USD	1 Quarter
Change in fair value of investment	`GainLossOnInvestments`	$-467.00K	USD	1 Quarter
Total other income (expenses)	`OtherNonoperatingIncomeExpense`	$-1.64M	USD	1 Quarter
Total other income (expenses)	`OtherNonoperatingIncomeExpense`	$268.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-3.96M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-3.54M	USD	1 Quarter
Deemed dividends related to Series O and Series P Redeemable Convertible Preferred Stock	`PreferredStockDividendsAndOtherAdjustments`	-	USD	1 Quarter
Deemed dividends related to Series O and Series P Redeemable Convertible Preferred Stock	`PreferredStockDividendsAndOtherAdjustments`	$3.01M	USD	1 Quarter
Net Loss Attributable to Common Shareholders	`NetIncomeLossAvailableToCommonStockholdersDiluted`	$-6.54M	USD	1 Quarter
Net Loss Attributable to Common Shareholders	`NetIncomeLossAvailableToCommonStockholdersDiluted`	$-3.96M	USD	1 Quarter
Basic and Diluted (in Dollars per share)	`EarningsPerShareBasic`	$-0.07	USD	1 Quarter
Basic and Diluted (in Dollars per share)	`EarningsPerShareBasic`	$-0.07	USD	1 Quarter
Basic and Diluted (in Shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	89.29M	shares	1 Quarter
Basic and Diluted (in Shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	60.28M	shares	1 Quarter

Cash Flow Statement 63 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-3.96M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-3.54M	USD	1 Quarter
Change in fair value of short-term investment	`ChangeInFairValueOfInvestments`	$886.00K	USD	1 Quarter
Change in fair value of short-term investment	`ChangeInFairValueOfInvestments`	$467.00K	USD	1 Quarter
Change in fair value of long-term investment	`GainLossOnSaleOfInvestments`	$1.41M	USD	1 Quarter
Research and development-acquired license, expensed	`ResearchAndDevelopmentacquiredLicenseExpensed`	$1.03M	USD	1 Quarter
Research and development-acquired license, expensed	`ResearchAndDevelopmentacquiredLicenseExpensed`	-	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$112.00K	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	-	USD	1 Quarter
Realized loss (gain) on marketable securities	`MarketableSecuritiesRealizedGainLoss`	$-224.00K	USD	1 Quarter
Realized loss (gain) on marketable securities	`MarketableSecuritiesRealizedGainLoss`	$424.00K	USD	1 Quarter
Unrealized loss on marketable securities	`MarketableSecuritiesUnrealizedGainLoss`	$-2.05M	USD	1 Quarter
Unrealized loss on marketable securities	`MarketableSecuritiesUnrealizedGainLoss`	$-333.00K	USD	1 Quarter
Realized gain on sale of digital currencies	`GainLossOnSaleOfOtherAssets`	-	USD	1 Quarter
Realized gain on sale of digital currencies	`GainLossOnSaleOfOtherAssets`	$64.00K	USD	1 Quarter
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-66.00K	USD	1 Quarter
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-16.00K	USD	1 Quarter
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-172.00K	USD	1 Quarter
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-323.00K	USD	1 Quarter
Accrued salaries and benefits	`IncreaseDecreaseInAccruedSalaries`	$5.00K	USD	1 Quarter
Accrued salaries and benefits	`IncreaseDecreaseInAccruedSalaries`	$6.00K	USD	1 Quarter
Interest receivable on convertible note	`IncreaseDecreaseInNotesReceivables`	$179.00K	USD	1 Quarter
Interest receivable on convertible note	`IncreaseDecreaseInNotesReceivables`	$27.00K	USD	1 Quarter
Deposits	`IncreaseDecreaseInSecurityDeposits`	-	USD	1 Quarter
Deposits	`IncreaseDecreaseInSecurityDeposits`	$7.00K	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-3.84M	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-1.05M	USD	1 Quarter
Purchase of marketable securities	`PurchaseOfMarketableSecurities`	$83.59M	USD	1 Quarter
Purchase of marketable securities	`PurchaseOfMarketableSecurities`	$27.10M	USD	1 Quarter
Sale of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$24.66M	USD	1 Quarter
Sale of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$14.34M	USD	1 Quarter
Proceeds from sale of digital currencies	`ProceedsFromSaleOfDatChatCommonShares`	-	USD	1 Quarter
Proceeds from sale of digital currencies	`ProceedsFromSaleOfDatChatCommonShares`	$93.00K	USD	1 Quarter
Purchase of short-term and long-term investments	`PaymentsToAcquireInvestments`	-	USD	1 Quarter
Purchase of short-term and long-term investments	`PaymentsToAcquireInvestments`	$7.74M	USD	1 Quarter
Purchase of research and development licenses	`UnpaidInvestment`	$-503.00K	USD	1 Quarter
Purchase of research and development licenses	`UnpaidInvestment`	-	USD	1 Quarter
Purchase of convertible note	`RepaymentOfConvertibleDebt`	-	USD	1 Quarter
Purchase of convertible note	`RepaymentOfConvertibleDebt`	$2.00M	USD	1 Quarter
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-10.08M	USD	1 Quarter
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-71.75M	USD	1 Quarter
Proceeds from issuance of common stock and warrants, net of offering cost	`ProceedsFromIssuanceCommonStockAndWarrantsNetOfOfferingCost`	$77.99M	USD	1 Quarter
Proceeds from issuance of common stock and warrants, net of offering cost	`ProceedsFromIssuanceCommonStockAndWarrantsNetOfOfferingCost`	-	USD	1 Quarter
Proceeds from issuance of Series O and Series P Redeemable Convertible Preferred Stock, net of discount and offering cost	`ProceedsFromIssuanceOfCommonStock`	$18.99M	USD	1 Quarter
Proceeds from issuance of Series O and Series P Redeemable Convertible Preferred Stock, net of discount and offering cost	`ProceedsFromIssuanceOfCommonStock`	-	USD	1 Quarter
Proceeds from exercise of warrants	`ProceedsFromWarrantExercises`	$84.00K	USD	1 Quarter
Proceeds from exercise of warrants	`ProceedsFromWarrantExercises`	-	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$18.99M	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$78.07M	USD	1 Quarter
Net increase in cash and cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$5.27M	USD	1 Quarter
Net increase in cash and cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$5.08M	USD	1 Quarter
Cash and cash equivalents and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$7.98M	USD	Point-in-time
Cash and cash equivalents and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$65.56M	USD	Point-in-time
Cash and cash equivalents and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$2.71M	USD	Point-in-time
Cash and cash equivalents and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$70.64M	USD	Point-in-time
Cash and cash equivalents and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$7.98M	USD	Point-in-time
Cash and cash equivalents and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$65.56M	USD	Point-in-time
Cash and cash equivalents and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$2.71M	USD	Point-in-time
Cash and cash equivalents and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$70.64M	USD	Point-in-time
Transfer from short-term investment to marketable securities	`TransferFromShorttermInvestmentToMarketableSecurities`	$1.48M	USD	1 Quarter
Transfer from short-term investment to marketable securities	`TransferFromShorttermInvestmentToMarketableSecurities`	-	USD	1 Quarter
Reclassify from convertible note receivable to notes receivable at fair value	`ReclassifyFromConvertibleNoteReceivableToNotesReceivableAtFairValue`	$2.15M	USD	1 Quarter
Reclassify from convertible note receivable to notes receivable at fair value	`ReclassifyFromConvertibleNoteReceivableToNotesReceivableAtFairValue`	-	USD	1 Quarter

Stockholders Equity 20 line items

Line Item	Tag	Value	Unit	Period
Net of offering costs	`WarrantNetOfferingCosts`	$8.26M	USD	1 Quarter
Balance	`StockholdersEquity`	$101.59M	USD	Point-in-time
Balance	`StockholdersEquity`	$104.37M	USD	Point-in-time
Balance	`StockholdersEquity`	$95.05M	USD	Point-in-time
Balance	`StockholdersEquity`	$29.62M	USD	Point-in-time
Issuance of Series O redeemable convertible preferred stock for cash	`StockIssuedDuringPeriodValueNewIssues`	-	USD	1 Quarter
Issuance of Series P redeemable convertible preferred stock for cash	`AdjustmentsToAdditionalPaidInCapitalWarrantIssued`	-	USD	1 Quarter
Cost on issuance of Series O and Series P Redeemable Convertible Preferred Stock	`StockIssuedDuringPeriodValueOther`	-	USD	1 Quarter
Deemed dividends related to Series O and Series P Redeemable Convertible Preferred Stock	`StockIssuedDuringPeriodValueConversionOfUnits`	$-3.01M	USD	1 Quarter
Cancellation of common stock related to investment in CBM	`DistributionOfHothCommonStock`	-	USD	1 Quarter
Issuance of common stock and warrants (net of offering costs of $8,260)	`StockIssuedDuringPeriodValueOfCommonStockAndWarrants`	$77.99M	USD	1 Quarter
Exercise of warrants	`StockIssuedDuringPeriodValueStockOptionsExercised`	$84.00K	USD	1 Quarter
Issuance of common stock for research and development license acquired	`StockIssuedDuringPeriodValueIssuedForResearchAndDevelopmentLicenseAcquired`	$531.00K	USD	1 Quarter
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition`	$112.00K	USD	1 Quarter
Net loss	`ProfitLoss`	$-3.96M	USD	1 Quarter
Net loss	`ProfitLoss`	$-3.54M	USD	1 Quarter
Balance	`StockholdersEquity`	$101.59M	USD	Point-in-time
Balance	`StockholdersEquity`	$104.37M	USD	Point-in-time
Balance	`StockholdersEquity`	$95.05M	USD	Point-in-time
Balance	`StockholdersEquity`	$29.62M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.